Health ❯ Healthcare ❯ Patient Safety ❯ Adverse Drug Reactions
The regulator said the drugs are unsuitable in pregnancy or breastfeeding because of fetal safety concerns, noting that Mounjaro can reduce oral contraceptive effectiveness in overweight women.
